Impact of Systemic Antibiotics on Staphylococcus aureus Colonization and Recurrent Skin Infection. (24th August 2017)

• Record Type: Journal Article
• Authors: Hogan, Patrick G; Rodriguez, Marcela; Spenner, Allison M; Brenneisen, Jennifer M; Boyle, Mary G; Sullivan, Melanie L; Fritz, Stephanie A
• Is Part Of: Clinical infectious diseases. Volume 66:Number 2(2018)
• Page Start: 191
• Page End: 197
• Publication Date: 2017-08-24
• Subjects: Staphylococcus aureus -- systemic antibiotics -- colonization -- SSTI; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/cix754
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract : In children with Staphylococcus aureus skin infection and colonization, systemic antibiotics in conjunction with incision and drainage reduced the likelihood of longitudinal colonization and recurrent infection. Clindamycin was superior to trimethoprim-sulfamethoxazole in eradicating S. aureus colonization and preventing recurrent infection. Abstract: Background: Staphylococcus aureus colonization poses risk for subsequent skin and soft tissue infection (SSTI). We hypothesized that including systemic antibiotics in the management of S. aureus SSTI, in conjunction with incision and drainage, would reduce S. aureus colonization and incidence of recurrent infection. Methods: We prospectively evaluated 383 children with S. aureus SSTI requiring incision and drainage and S. aureus colonization in the anterior nares, axillae, or inguinal folds at baseline screening. Systemic antibiotic prescribing at the point of care was recorded. Repeat colonization sampling was performed within 3 months (median, 38 days; interquartile range, 22–50 days) in 357 participants. Incidence of recurrent infection was ascertained for up to 1 year. Results: Participants prescribed guideline-recommended empiric antibiotics for purulent SSTI were less likely to remain colonized at follow-up sampling (adjusted hazard ratio [aHR], 0.49; 95% confidence interval [CI], .30–.79) and less likely to have recurrent SSTI (aHR, 0.57; 95% CI, .34–.94) than those not receiving guideline-recommended empiric antibiotics for their SSTI. Additionally, participants remaining colonized at repeat sampling were more likely to report a recurrent infection over 12 months (aHR, 2.37; 95% CI, 1.69–3.31). Clindamycin was more effective than trimethoprim-sulfamethoxazole (TMP-SMX) in eradicating S. aureus colonization (44% vs 57% remained colonized, P = .03) and preventing recurrent SSTI (31% vs 47% experienced recurrence, P = .008). Conclusions: Systemic antibiotics, as part of acute SSTI management, impact S. aureus colonization, contributing to a decreased incidence of recurrent SSTI. The mechanism by which clindamycin differentially affects colonization and recurrent SSTI compared to TMP-SMX warrants further study.